Target intelligence / Profile preview

Chloride voltage-gated channel 2 (CLCN2) (CLCN2)

Target
CLCN2
Molecular classification
Ion channel, Voltage-gated chloride channel, CLC family
01

Overview

Chloride voltage-gated channel 2 (CLCN2), also known as ClC-2, is a widely expressed transmembrane protein that facilitates the movement of chloride ions across cell membranes in response to hyperpolarization, cell swelling, and low pH. In the peripheral nervous system, it is expressed in both neurons and glial cells, such as Schwann cells, where it plays a critical role in maintaining chloride homeostasis and regulating membrane excitability. By providing a background chloride conductance, CLCN2 helps stabilize the resting membrane potential and prevents the development of ectopic discharges that can lead to neuropathic pain. Mutations in the CLCN2 gene are primarily associated with leukoencephalopathy and certain forms of epilepsy, highlighting its importance in myelin stability and neuronal network balance. Pharmacologically, CLCN2 is targeted by activators like lubiprostone to enhance chloride secretion in epithelial tissues, while its role in the nervous system makes it a potential target for modulating nerve conduction and treating sensory disturbances.

Other names
ClC-2Chloride channel protein 2CLC2Voltage-gated chloride channel 2Chloride channel, voltage-sensitive 2
02

Mechanism of action

Activation of CLCN2 increases chloride conductance, which typically stabilizes the resting membrane potential and prevents hyperexcitability in neurons and glia. Inhibition of the channel reduces chloride efflux, which can lead to membrane depolarization and increased excitability or impaired volume regulation.

03

Biological functions

Chloride homeostasisMembrane potential regulationCell volume regulationNeuronal excitabilityTransepithelial transportChloride extrusion
04

Disease associations

LeukoencephalopathyEpilepsyHyperaldosteronismNeuropathic painRetinal degeneration
05

Safety considerations

Gastrointestinal distress (nausea, diarrhea)Potential for seizures if CNS homeostasis is disruptedVisual impairment due to retinal roleElectrolyte imbalances
06

Interacting drugs

Lubiprostone

5 more in the full profile.

07

Biomarkers

CLCN2 gene mutationsIntracellular chloride concentrationNerve conduction velocityMyelin vacuolation (imaging)

Beyond the preview

Go deeper on Chloride voltage-gated channel 2 (CLCN2) (CLCN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride voltage-gated channel 2 (CLCN2) (CLCN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call